Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Vital-Net: Operating Profits Drop Despite Big Increases in Sales
December 10, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
December 10, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -2-
December 10, 2001
- GEYMS: Top of the Line LOGIQ Ultrasound Device Introduced
December 3, 2001
- Listed Wholesalers' Profits Plummet Despite Increases in Sales
December 3, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 3, 2001
- BUSINESS NEWS IN BRIEF
December 3, 2001
- WORLD NEWS IN BRIEF
December 3, 2001
- Aiming at \2 Trillion Sales in FY2009: Kuraya Sanseido President
December 3, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
December 3, 2001
- Kissei Withdraws Additional Indication Application for Rizaben
December 3, 2001
- Nippon Roche, GSK/IPF Hold Seminars on Influenza
December 3, 2001
- Otsuka Signs Contract with Celera Genomics for Genomic Database
December 3, 2001
- OTC NEWS IN BRIEF
December 3, 2001
- Kyorin Beefs Up Globalization by Forming Subsidiary in Europe
December 3, 2001
- Semi-annual Sales of OTC Drugs Up 1.1% from Last Year: INTAGE Survey
December 3, 2001
- REGULATORY NEWS IN BRIEF
December 3, 2001
- Current Price Gap Estimated to Be About 8%
December 3, 2001
- Decreases in Medical Fees Not Proposed by Gov't WT
December 3, 2001
- Ono to Start Overseas Business in Earnest: President Matsumoto
December 3, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…